The latest closing stock price for Aprea Therapeutics as of November 12, 2024 is 3.43.
An investor who bought $1,000 worth of Aprea Therapeutics stock at the IPO in 2019 would have $-992 today, roughly -1 times their original investment - a -61.58% compound annual growth rate over 5 years.
The all-time high Aprea Therapeutics stock closing price was 990.60 on December 27, 2019.
The Aprea Therapeutics 52-week high stock price is 8.85, which is 158% above the current share price.
The Aprea Therapeutics 52-week low stock price is 2.15, which is 37.3% below the current share price.
The average Aprea Therapeutics stock price for the last 52 weeks is 4.63.
An investor who bought $1,000 worth of Aprea Therapeutics stock at the IPO in 2019 would have $-992 today, roughly -1 times their original investment - a -61.58% compound annual growth rate over 5 years.
The all-time high Aprea Therapeutics stock closing price was 990.60 on December 27, 2019.
The Aprea Therapeutics 52-week high stock price is 8.85, which is 158% above the current share price.
The Aprea Therapeutics 52-week low stock price is 2.15, which is 37.3% below the current share price.
The average Aprea Therapeutics stock price for the last 52 weeks is 4.63.